About Us

GBR is a Private entity, with its line of activities is Primarily manufacturing Active Pharmaceutical Ingredients(API’s) and an end-to-end solution provider for serious or life-threatening respiratory diseases. Our management team has significant experience to development and commercialization of Pulmonary medicine, Innovate to deliver cost effective products and services, identifying unmet needs, and integrated pulmonary drug delivery solutions. Our team has the potential to address major unmet needs associated with pulmonary disorders, chronic infection and related mucus accumulation and inflammation.

​

GBR has a portfolio of over 15 process patents. Our R&D team is currently focusing on the understanding of the underlying mechanisms of diseases, targeted therapy and minimize the drug dosage with maximum efficacy.